Results 201 to 210 of about 855,762 (278)

Combating antibiotic resistance in a one health context: a plethora of frontiers. [PDF]

One Health Outlook
Ajose DJ, Adekanmbi AO, Kamaruzzaman NF, Ateba CN, Saeed SI.   +4 more
europepmc   +1 more source

Chemotherapy-Induced Jejunal Perforations as an Atypical Presentation of Neutropenic Enterocolitis in an Acute Leukemia Patient. [PDF]

Cureus
Zvizdic Z, Jonuzi A, Pilav L, Sefic Pasic I, Vranić S.   +4 more
europepmc   +1 more source

Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis. [PDF]

BMC Womens Health
Wen Q, Wang S, Min Y, Liu X, Fang J, Lang J, Chen M.   +6 more
europepmc   +1 more source

Quinolin-4-ones: Methods of Synthesis and Application in Medicine. [PDF]

Molecules
Gach-Janczak K, Piekielna-Ciesielska J, Waśkiewicz J, Krakowiak K, Wtorek K, Janecka A.   +5 more
europepmc   +1 more source

Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS). [PDF]

BMC Pharmacol Toxicol
Qu Y, Wang S, Xie H, Meng X, Cui B, Xiao Z.   +5 more
europepmc   +1 more source

Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials

Exploration, EarlyView.
Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment, has been emerging as a key participant and driving factor in cancer. This article reviews the latest progress in this field, including the microbial community within tumors and its pro‐cancer mechanisms, as well as the anti‐tumor strategies targeting intra‐tumoral ...
Yanan Niu, Junya Feng, Jie Ma, Tixian Xiao, Wei Yuan   +4 more
wiley   +1 more source

Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016-2022 review data. [PDF]

Front Pharmacol
Lan Y, Lin X, Yu J, Wang L, Sun L, Huang Z.   +5 more
europepmc   +1 more source

Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application

Exploration, EarlyView.
This perspective highlights synthetic biology‐driven antibacterial strategies, focusing on three innovative approaches: engineered bacteriophages for precision bacterial targeting, reprogrammed microbes that detect quorum‐sensing signals or metabolites to release antimicrobials, and engineering mammalian cells that recognize pathogen‐associated ...
Shun Huang, Shuihao Zhao, Haijie Zhao, Mingzhang Wen, Zhong Guo   +4 more
wiley   +1 more source

The role of residual (veterinary) antibiotics in chemical exposome analysis: Current progress and future perspectives. [PDF]

Compr Rev Food Sci Food Saf
Hossain MZ, Feuerstein ML, Warth B.
europepmc   +1 more source

Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol

Exploration, EarlyView.
Using celastrol as a case study, this review summarizes various target discovery strategies for natural products, including chemical proteomics, protein microarray, degradation‐based protein profiling, proteome‐wide label‐free approaches, network pharmacology, target‐based drug screening, and indirect strategies.
Yanbei Tu, Guiyu Dai, Yanyan Chen, Lihua Tan, Hanqing Liu, Meiwan Chen   +5 more
wiley   +1 more source